Global Medical Lead at Caelum Biosciences - New York, New York, United States
President and Chief Executive Officer
Contact Michael Spector
Caelum Biosciences is a New York-based biotechnology company that develops and commercializes drugs for the treatment of AL amyloidosis and hematologic disorders.